Submitted by Anonymous (not verified) on 13 August 2026 - 8:35
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 50, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 50, Status: Authorised